Detection rates of abnormalities in over 10,000 amniotic fluid samples at a single laboratory

• Published in: BMC pregnancy and childbirth 2023-02, Vol.23 (1), p.102-102, Article 102
• Main Authors: Lu, Sha, Kakongoma, Nisile, Hu, Wen-Sheng, Zhang, Yan-Zhen, Yang, Nan-Nan, Zhang, Wen, Mao, Ai-Fen, Liang, Yi, Zhang, Zhi-Fen
• Format: Article
• Language: English
• Subjects: Age; Amniocentesis; Amniotic Fluid; Amniotic fluid sample; Aneuploidy; Birth defects; BoBs assay; Chromosome Disorders - diagnosis; DNA Copy Number Variations; Female; Genetic counseling; Genomes; Humans; Infant mortality; Karyotyping; Laboratories; Medical diagnosis; Polymorphism; Pregnancy; Prenatal diagnosis; Prenatal Diagnosis - methods; Radiation; Retrospective Studies; Sex chromosomes; SNP array; Software; Ultrasonic imaging; Womens health
• ISSN: 1471-2393; 1471-2393
• DOI: 10.1186/s12884-023-05428-5

A growing number of cytogenetic techniques have been used for prenatal diagnosis. This study aimed to demonstrate the usefulness of karyotyping, BACs-on-Beads (BoBs) assay and single nucleotide polymorphism (SNP) array in prenatal diagnosis during the second trimester based on our laboratory experience. A total of 10,580 pregnant women with a variety of indications for amniocentesis were enrolled in this retrospective study between January 2015 and December 2020, of whom amniotic fluid samples were analysed in 10,320 women. The main technical indicators of participants in the three different technologies were summarized, and cases of chromosome abnormalities were further evaluated. The overall abnormality detection rate of karyotyping among all the amniotic fluid samples was 15.4%, and trisomy 21 was the most common abnormality (20.9%). The total abnormality detection rate of the BoBs assay was 5.6%, and the diagnosis rate of microdeletion/microduplication syndromes that were not identified by karyotyping was 0.2%. The detection results of the BoBs assay were 100.0% concordant with karyotyping analysis in common aneuploidies. Seventy (87.5%) cases of structural abnormalities were missed by BoBs assay. The total abnormality detection rate of the SNP array was 21.6%. The detection results of common aneuploidies were exactly the same between SNP array and karyotyping. Overall, 60.1% of structural abnormalities were missed by SNP array. The further detection rate of pathogenic significant copy number variations (CNVs) by SNP was 1.4%. Karyotyping analysis combined with BoBs assay or SNP array for prenatal diagnosis could provide quick and accurate results. Combined use of the technologies, especially with SNP array, improved the diagnostic yield and interpretation of the results, which contributes to genetic counselling. BoBs assay or SNP array could be a useful supplement to karyotyping.